Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.
Pohlen
Michele
M
Sargin
Bülent
B
Zicholl
Stefan
S
Bisping
Guido
G
Müller-Tidow
Carsten
C
Berdel
Wolfgang E
WE
Mesters
Rolf
R
Koschmieder
Steffen
S
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008875:Middle Aged; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D011961:Receptors, Fc / Q000008:administration & dosage*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D012074:Remission Induction; D000069283:Rituximab; D013926:Thrombopoietin / Q000008:administration & dosage*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007155:Immunologic Factors; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D000069283:Rituximab; D013926:Thrombopoietin; C488777:romiplostim